StockTipsArenaBeta

BUY Piramal Pharma Limited — Rajesh Palviya, Axis Securities

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))30 Jul 2026via Business Today

Entry₹194.99Inferred
Target₹210
Total upside +7.70% (call closed)
Stop loss₹189-3.07% risk
Exit₹2106 Aug 2026, 9:25 am
Target hit+7.70%0.00%upside left
Follow Rajesh Palviya for new calls(27% target hit, 176 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 6 Aug 2026
8 supporting4 neutral3 opposing
Supports the BUY call (8)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·3 Aug · 2d ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·30 Jul · 6d ago

Piramal Pharma narrows Q1 loss as revenue jumps 17%, EBITDA nearly doubles

NewsCnbc-Tv18·29 Jul · 1w ago

(opens in new tab)

Q1 Results Highlights: Piramal Pharma Loss Narrows; Eicher Motors Profit Jumps Over 21%; Waaree Energies Revenue Soars 79%

NewsNdtv-Profit·29 Jul · 1w ago

(opens in new tab)

Piramal Pharma Q1 Results: Net Loss Narrows As Margin Expands; Revenue Up 17%

NewsNdtv-Profit·29 Jul · 1w ago

(opens in new tab)
Neutral / worth noting (4)

Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit

NewsNdtv-Profit·30 Jul · 6d ago

(opens in new tab)

Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·29 Jul · 1w ago

(opens in new tab)

Piramal Pharma temporarily suspends Ahmedabad plant operations due to heavy rainfall

NewsCnbc-Tv18·25 Jul · 2w ago

(opens in new tab)

Piramal Pharma, Authum Investment, Vaibhav Global Show Technical Breakouts

NewsGoogle News·20 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (3)

HDFC Mutual Fund reduces stake in Piramal Pharma by 2.005%

NewsGoogle News·18 Jul · 3w ago

(opens in new tab)

HDFC Mutual Fund ने Piramal Pharma मधील हिस्सा विकला, मोठी घट!

NewsGoogle News·17 Jul · 3w ago

(opens in new tab)

HDFC Mutual Fund Sells 2% Stake in Piramal Pharma

NewsGoogle News·17 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Rajesh Palviya, Axis Securities

Every call and its outcome